Details of the Drug

General Information of Drug (ID: DMN03YW)

• Drug Name: TAK-105

Indication

Disease Entry	ICD 11	Status	REF
Nausea and vomiting	MD90	Phase 1	[1]

• Cross-matching ID: TTD ID: DHQD71

References

• [1] ClinicalTrials.gov (NCT04964258) A Randomized, Double-Blind, Sponsor-Open, Placebo-Controlled, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TAK-105 in Healthy Subjects. U.S.National Institutes of Health.